chrisvoncsefalvay/vaers-outcomes huggingface dataset:
When she starts sneezing like this, she then stars coughing and her nose stops up; When she starts sneezing like this, she then stars coughing and her nose stops up; picked up an allergy; she began sneezing on the way to get the second dose the Covid 19 vaccine today and has not stopped since; This is a spontaneous report from a contactable consumer. This consumer reported for herself that a 84-years-old female patient received bnt162b2 (BNT162B2; PFIZER-BIONTECH COVID-19 VACCINE; Batch/lot number: EL3247) first dose, via an unspecified route of administration on 02Jan2021 at SINGLE DOSE for covid-19 immunisation. The patient's medical history and concomitant medications were not reported. The patient experienced she began sneezing on the way to get the second dose the covid 19 vaccine today and has not stopped since on 22Jan2021, when she starts sneezing like this, she then stars coughing and her nose stops up on an unspecified date, picked up an allergy on an unspecified date.  Patient stated she began sneezing on the way to get the second dose the Covid 19 vaccine today and has not stopped since.  She would like to know if she could take a Benadryl.  When she started sneezing like this, she then started coughing and her nose stopped up. She was experiencing all these symptoms currently.  The patient had a question: she had the second dose of Pfizer COVID vaccine, may she took a Benadryl, she didn't want anything to affect the vaccine working, someone suggested not taking things like aspirin, Aleve, Tylenol, 24 hours after the vaccine, as it may effect the potency. She sneezed before the shot, now she was not blaming the shot, she went out and walked this morning and may have picked up an allergy, but she sneezed all the way to the shot, and she has been sneezing all afternoon and her nose was stopped up, she wanted to know if can take Benadryl, she wanted to clarify this started before she had the shot. She hasn't had this in years this bad, she was stopped up this afternoon, and thought to take a Benadryl that can help this, but she didn't want to mess the shot up. The outcome of event sneezing was not recovered, outcome for other events was unknown.
Pt had SIRVA from a vaccine that was given too high, and is complaining of muscle stiffness and arm pain.
came out positive for Covid-19; came out positive for Covid-19; This is a spontaneous report from a contactable pharmacist.  A male patient of an unspecified age received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration in 29Dec2020 at a single dose for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported.  The patient came out positive for covid-19 on 30Dec2020 and inquired if he should still get the 2nd dose.   Information on the lot/batch number has been requested.
got her second vaccine on 5/23/2022; dizziness/lightheadedness; brain and ear zaps; This case was reported by a consumer via call center representative and described the occurrence of dizziness in a 74-year-old female patient who received Herpes zoster (Shingrix) (batch number x2e93, expiry date 6th May 2023) for prophylaxis.   Previously administered products included Shingrix with an associated reaction of injection site pruritus (received 1st dose on 9th May 2022 experienced injection site pruritus refer case US2022083402) and COVID booster (received 2nd dose of COVID booster).   On 23rd May 2022, the patient received the 2nd dose of Shingrix (intramuscular) .5 ml. In May 2022, 12 hrs after receiving Shingrix, the patient experienced dizziness and brain zaps. On 23rd May 2022, the patient experienced drug administration duration too short. On an unknown date, the outcome of the dizziness and brain zaps were not recovered/not resolved and the outcome of the drug administration duration too short was unknown.   It was unknown if the reporter considered the dizziness and brain zaps to be related to Shingrix.     Linked case(s) involving the same patient: US2022083402   Additional Information: GSK Receipt Date: 24-MAY-2022 Reporter's Comments: The case was self reported by the patient. The patient received Shingrix in the left deltoid. On 24th may 2022, about 12 hours after receiving Shingrix vaccine, she started with dizziness/lightheadedness and what she described as brain and ear zaps. These symptoms were still present. The reporter consented to follow up. Additional supportive information: The patient received the Shingrix dose earlier than the recommended interval, which led to shortening of vaccination schedule.; Sender's Comments:  US-GLAXOSMITHKLINE-US2022083402:same reporter
Pt did not wake up the morning after shots were given. Autopsy gives cause of death as positional asphyxia
Faint erythematous rash. Near the site of injection. No signs of RDS. Normal vital signs. Did improve without intervention.
product expired 05/22/2022; This case was reported by a other health professional via call center representative and described the occurrence of expired vaccine used in a 46-year-old female patient who received HAB (Twinrix) (batch number A955S, expiry date 22nd May 2022) for prophylaxis.   Co-suspect products included hepatitis A and hepatitis B vaccine pre-filled syringe device (Twinrix Pre-Filled Syringe Device) injection syringe for prophylaxis.   On 3rd June 2022, the patient received the 2nd dose of Twinrix and Twinrix Pre-Filled Syringe Device. On 3rd June 2022, unknown after receiving Twinrix and Twinrix Pre-Filled Syringe Device, the patient experienced expired vaccine used. On an unknown date, the outcome of the expired vaccine used was unknown.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.   Additional Information: GSK receipt date: 6-Jun-2022 Reporter's comment: The reporter was a medical assistant calling from a clinic on behalf of the patient.  The reporter stated that the patient received Twinrix on the day of reporting in left deltoid which was already expired on 22nd May 2022. The reporter did not consent to follow-up. Additional supportive information: The patient received an expired dose of Twinrix, which led to expired vaccine used.
No adverse event; Gave a Moderna Bivalent vaccine Friday 18-Aug-2023 and when they looked up the lot number it says it expired on 01-Jun-2023; 58 years old patient received Moderna Bivalent as first dose.; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Gave a Moderna Bivalent vaccine Friday 18-Aug-2023 and when they looked up the lot number it says it expired on 01-Jun-2023), WRONG PRODUCT ADMINISTERED (58 years old patient received Moderna Bivalent as first dose.) and NO ADVERSE EVENT (No adverse event) in a 58-year-old female patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. 021H22A) for COVID-19 prophylaxis.     Patient had no relevant medical history or conditions, allergy, concomitant diseases and risk factor.     On 18-Aug-2023, the patient received first dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On 18-Aug-2023, the patient experienced EXPIRED PRODUCT ADMINISTERED (Gave a Moderna Bivalent vaccine Friday 18-Aug-2023 and when they looked up the lot number it says it expired on 01-Jun-2023) and WRONG PRODUCT ADMINISTERED (58 years old patient received Moderna Bivalent as first dose.). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Gave a Moderna Bivalent vaccine Friday 18-Aug-2023 and when they looked up the lot number it says it expired on 01-Jun-2023), WRONG PRODUCT ADMINISTERED (58 years old patient received Moderna Bivalent as first dose.) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for EXPIRED PRODUCT ADMINISTERED (Gave a Moderna Bivalent vaccine Friday 18-Aug-2023 and when they looked up the lot number it says it expired on 01-Jun-2023) and WRONG PRODUCT ADMINISTERED (58 years old patient received Moderna Bivalent as first dose.).    Concomitant product use was not provided by the reporter.  Individual vials size was 2.5 ml. Vial was initially stored in the refrigerator on 11-Aug-2023. Vial did not undergo any temperature excursions.  Treatment information was not provided.
Patient waited 30 min given prior history of reactions to medications (rash, no anaphylaxis) with other medications. Left after 30 min with no complaint.   Allergies Allergen Reactions ? Niacin Other (See Comments)     Other Reaction: Other reaction ? Penicillins Rash ? Amlodipine Swelling ? Flagyl [Metronidazole Hcl] Other (See Comments)     Other Reaction: Other reaction ? Lipitor [Atorvastatin] Rash ? Zocor [Simvastatin] Other (See Comments) and Unknown     Other Reaction: Other reaction ? Colesevelam Other (See Comments)     severe ? Metronidazole Rash ? Colesevelam Hcl Other (See Comments)     severe   She returned after approximately another 20 minutes to report rash and mild pruritis on upper chest and face.   No complaints of shortness of breath, chest tightness, lightheadedness or dizziness.   No facial swelling, pallor or cyanosis.  No increased effort of breathing or wheezing appreciated.    Skin only reaction, no respiratory, cardiovascular or GI reaction.    On exam-  140/70 HR regular rate and rhythm.   Lungs clear No cyanosis or pallor noted Patient able to converse normally, A+O , in no acute distress Mild erythema around mouth, no tongue swelling appreciated. Mild erythema between brows. Mild blotchy erythema on upper chest.     Given oral diphenhydramine 25 mg at 4:30.  No progression of symptoms and patient observed another 30 minutes without change.     Given a oral diphenhydramine 25 mg to take with her in the event symptoms progress or to take as a second dose in 4 hrs.  If any worsening symptoms she is to seek emergency medical attention.     I will follow up with her this evening and tomorrow.  I will provider her formal recommendations regarding her second vaccination.     I spoke with her at 6:50- she is stable, still mild rash on upper chest, but no new symptoms.  She will repeat with diphenhydramine 25 mg at 8 pm and I will check on her tomorrow.  She is motivated to receive her second dose but asks if receiving a different medication is an option  We will discuss this further tomorrow.     I spoke with patient again on 1/21/21 at 8:30 am.  She continues with mild rash on upper chest, will continue benedryl for mild itching, but no further progression of rash, no residual facial erythema and no shortness of breath or other new symptoms.  I have asked her to consider premedicating with 50 mg diphenhydramine 1 hr prior to dose 2 of vaccine.  I have also asked her to register with v-safe and have sent her the information in case she did not keep the paperwork.     Pt then saw PCP several days later who suggested she not receive second vaccination
Patient was light headed, pulse rapid sweating and pale. we had him lay flat on the floor for a few minutes. He stated he hadn't eaten or had any water today. Once he was sitting upright he drank a bottle of water and ate a sleeve of crackers. He was also shaking like he was cold which lasted for about 15 minutes and then resolved. Patient was concious and talking the whole time. He also said he just didn't feel right.
Congestive Heart Failure; This spontaneous case was reported by a consumer and describes the occurrence of CARDIAC FAILURE CONGESTIVE (Congestive Heart Failure) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    In January 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced CARDIAC FAILURE CONGESTIVE (Congestive Heart Failure). At the time of the report, CARDIAC FAILURE CONGESTIVE (Congestive Heart Failure) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medication were not provided.  Treatment medications were not provided.  Patient stated that she had first set of vaccine one month ago and was asked if it was ok to get the second shot of vaccine if she had Congestive Heart failure.  Company comment: This case concerns a female patient, with no medical history reported in this case, who experienced the non-serious AESI of Cardiac failure congestive. The event occurred on an unknown date after the administration of the first dose of the mRNA-1273 vaccine. No further information was provided.  The rechallenge is unknown since no further information has been disclosed. The benefit-risk relationship of mRNA-1273 vaccine is not affected by this report. A discrepancy remains whether the event occurred after the administration of the vaccine or if it was a previous medical condition.; Sender's Comments: This case concerns a female patient, with no medical history reported in this case, who experienced the non-serious AESI of Cardiac failure congestive. The event occurred on an unknown date after the administration of the first dose of the mRNA-1273 vaccine. No further information was provided.  The rechallenge is unknown since no further information has been disclosed. The benefit-risk relationship of mRNA-1273 vaccine is not affected by this report. A discrepancy remains whether the event occurred after the administration of the vaccine or if it was a previous medical condition.
Patient had syncope with partial seizure after receiving MCV4 and HPV#2. Seizure episode lasted about a minute. O2 given, vitals taken, and glucose checked. Patient stabilized and in stable condition upon discharge.
I have had pain in my calves so I stopped the birth control mini pill. My period had also been incredibly irregular, super heavy and clotted bleeding. I?ve felt dizzy and weak on the heaviest days I?ve been bleeding as well.  I?m passing clots - similar to when I?ve miscarried in the past.
herpes simplex dendritic keratitis; This spontaneous report was received from a lawyer referring to a female patient (pt) of unknown age. Information regarding current condition, historical condition or concomitant medication was not reported. On or around 12-SEP-2016, the pt was vaccinated with zoster vaccine live (ZOSTAVAX) (strength, route, dose number, batch/lot# and expiration date were unknown) for routine health maintenance and for its intended purpose: the prevention of shingles (herpes zoster). On an unknown date, shortly after receiving zoster vaccine live (ZOSTAVAX), the pt suffered blurred vision and was diagnosed with herpes simplex dendritic keratitis. As a direct and proximate result of zoster vaccine live (ZOSTAVAX), the pt's symptoms had resulted in physical limitations not presented prior to using the vaccine. The pt also experienced mental and emotional distress due to resulting physical limitations and seriousness of her condition. As a result of the manufacture, marketing, advertising, promotion, distribution and/or sale of zoster vaccine live (ZOSTAVAX), the pt sustained severe and permanent personal injuries. Further, as a tragic consequence of the wrongful conduct, the pt suffered serious, progressive, permanent, and incurable injuries, as well as significant conscious pain and suffering, mental anguish, emotional distress, loss of enjoyment of life, physical impairment and injury. As a direct and proximate result, the pt had suffered and incurred damages, including medical expenses; the loss of accumulations; and other economic and non-economic damages. The outcome of the event was considered as not recovered. The reporter considered the event to be related to zoster vaccine live (ZOSTAVAX).  Herpes simplex dendritic keratitis was considered as disabling. Upon internal review, herpes simplex dendritic keratitis was considered as medically significant.
my friend's grandmother died; This is a spontaneous report from a contactable consumer reported for friend's grandmother via a female patient of an unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE), via an unspecified route of administration on an unspecified date (Lot number was not reported) as dose number unknown, single for covid-19 immunisation. The patient medical history and concomitant medications were not reported. The reporter stated that her friend's grandmother died with the Pfizer COVID 19 vaccine on an unspecified date. It was not reported if an autopsy was performed.  The lot number for BNT162B2 was not provided and will be requested during follow up.; Reported Cause(s) of Death: my friend's grandmother died
Son had fever from the last dose; This is a spontaneous report received from a non-contactable consumer (patient's mother) via Pfizer Sponsored Program. A male patient of unspecified age received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Solution for injection, Lot Number: UNKNOWN), via an unspecified route of administration on an unknown date as a single dose for COVID-19 immunization. The patient medical history and concomitant medications were not reported. On an unspecified date, after first vaccine, the patient had fever. Reporter stated that second dose was schedule for 19 days instead of 21 days and wanted to know if she was able to schedule it for the 21 days according to the information she found. The outcome of the event was unknown.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Information has been received from a physician concerning a female patient with allergy to unknown medications who on unspecified dates was vaccinated with the first and the second doses of GARDASIL (lot # and expire date not reported), 0.5 ml, intramuscularly. The physician stated that on unspecified dates, the patient broke out in a rash after the first GARDASIL dose and worse rash after the second GARDASIL dose. On an unspecified date, allergy testing was performed (results not provided) and unspecified treatment was given to the patient. Therapy with GARDASIL was discontinued and not reintroduced. It was unknown if the patient sought medical attention. At the time of the report, the patient's outcome was unknown. Additional information has been requested.
NO NEGATIVE OUTCOME AFTER RECEIVING COVID VACCINE. RESIDENT DIED IN HOUSE AS COMFORT MEASURES PRIOR TO COVID POSITIVE TEST RESULT
Patient admitted to Hospital with pneumonia, difficulty breathing, neg for PE. Shortness of breath , subjective fever and cough , few days symptoms began over weekend, approximately 7/31. Patient has history of COPD and pancreatic cancer, with treatment completed about one month before vaccination.
Patient started developing rash/hives on the back of his knees 1.5 hours after the shot.
Within 12 hours my arm was sore/red/hot/rash at the injection site and well as a 1/2" band half way around my arm just below the injection site. During the night I experienced pain all the way down my arm and into my hand. My fingers felt numb/tingly. This continued for about 12 hours. My upper arm continued to be sore/red/hot/rash for another 5 days. As of today (8/7/19) there is still a slight rash on my upper arm
9/16/99 woke up w/ h/a, fever, fatigue, pain in both arms;
This spontaneous report as received from a pharmacist via company representative refers to a patient of unknown age and gender. No information on patient's medical history and concurrent conditions was provided. On an unknown date, the patient was vaccinated with a dose of ZOSTAVAX (dose, route, lot # and expiration date was not reported). Concomitant therapy was not provided. On an unknown date after the injection, the patient's ZOSTAVAX injection site "swelled up like a golf ball". The patient sought medical attention by speaking with the pharmacist. The outcome of the event was unknown. The relatedness between the event and the vaccination with ZOSTAVAX was not provided. Additional information has been requested.
Had nightmares; Had a lump that grew to a softball size; Her right shoulder hurt; Right shoulder developed a golf ball-sized lump; This spontaneous case was reported by a consumer and describes the occurrence of NIGHTMARE (Had nightmares), SWELLING (Had a lump that grew to a softball size), SWELLING (Right shoulder developed a golf ball-sized lump) and ARTHRALGIA (Her right shoulder hurt) in a 55-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 03-May-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .5 milliliter. On 03-May-2021, the patient experienced SWELLING (Right shoulder developed a golf ball-sized lump). On 10-May-2021, the patient experienced NIGHTMARE (Had nightmares), SWELLING (Had a lump that grew to a softball size) and ARTHRALGIA (Her right shoulder hurt). On 06-May-2021, SWELLING (Right shoulder developed a golf ball-sized lump) had resolved. At the time of the report, NIGHTMARE (Had nightmares), SWELLING (Had a lump that grew to a softball size) and ARTHRALGIA (Her right shoulder hurt) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   On 03 May 2021 patient developed a golf ball-sized lump on her right shoulder which went away on 06 May 2021.On 10 May 2021,her right shoulder hurt and had a lump that grew to a softball size and also had nightmares.No concomitant medications were reported.No treatment information was provided.
32 year old male soldier developed recurring fevers starting on 11/03/06 associated with myalgias, and malaise.  Chest pain then developed by the evening of 11/05/06 prompting a visit to the Emergency room and subsequent hospitalization.  Fever Start: 11/03/2006 End: 11/07/2006 Comment: The maximum fever over the weekend prior to hospitalization was 101F.  Chills Start: 11/03/2006 End: 11/07/2006 Comment: Associated with fevers.  Muscle pain Start: 11/03/2006 End: 11/07/2006 Comment: Patient noted multiple myalgias in association with fever and chills.. Chest pain developed on the evening of 11/5 prompting the ER visit.  Vomiting Start: 11/05/2006 End: 11/05/2006 Comment: Patient vomited x 1 on his way to the hospital.  11/20/06 Received medical records which reveal patient admitted to hospital 11/6-11/7/06 after presenting to ER with N/V, chest pain, fever, chills & myalgias for 3 days & 11 days s/p vax.  Then had sharp chest pain on 11/5 which worsened overnight.  On admit, temp 100.7, tachycardic.  Admitted to CCU & treated symtomatically with NSAIDS & hydration.   Final Dx: myocarditis./ss
Pt. states that after receiving the 2nd dose of Moderna 02/18/2021, started experiencing symptoms 07/04/2021 (Breakthrough Case) Covid + 07/04/2021, bladder control issues, Neuropathy in both knees, and accelerated Arthritis throughout the limbs.
on the date mentioned was injected with Spikevax 12+ BPK 23-24 in the early afternoon. after a few hours, the arm injected became increasingly sore and had the feeling of weightedness and immobility. was awoken in the night with deep chills and visible trembling . side affects abated in the late afternoon the next day. a lite soreness persists at the injection site, but the worst of tie, the chills and trembling are now nonexistent
Sore arm only after 1st injection, 2nd inject, sore arm, next day aches all over, fatigue, no fever or other associated symptoms